"Irish Gossamer" is now available to stream for free from the Irish Film Institute's IFI Archive Player. Commissioned by the Irish tourism board Bord Fáilte to entice visitors to Ireland, this ...

Consider investing in some of the best motivational books to get you back in gear. Whether you’re on the hunt for a new inspirational read to flip through to resurge your motivation or are ...

Check out new books by Sally Rooney, Rachel Kushner and Richard Powers, and revisit familiar worlds from Karl Ove Knausgaard, Haruki Murakami and Jeff VanderMeer. Buenos Aires is a literary city ...

Gossamer Bio's seralutinib shows promise for PAH and PH-ILD, with a clean long-term safety profile differentiating it from competitors like Winrevair. AVTE's AV-101 failed due to dose limitations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Winter is here, which means it’s time to pick up a great book to get all cozy with (or, rather, sign up for audible to listen on the go). It’s never been a better time to pick up a new read ...

Oppenheimer has recently initiated Gossamer Bio Inc (GOSS) stock to Outperform rating, as announced on June 25, 2024, according to Finviz. Earlier, on April 5, 2024, Wedbush had resumed the stock to ...

Gossamer Bio Inc (GOSS) stock saw a decline, ending the day at $0.91 which represents a decrease of $-0.05 or -5.21% from the prior close of $0.96. The stock opened at $0.97 and touched a low of $0.87 ...

Gossamer Bio, Inc. (NASDAQ:GOSS) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's forecasts. The consensus statutory numbers for both ...

This is an edition of the Books Briefing, our editors’ weekly guide to the best in books. Sign up for it here. This week, Sophie Vershbow asked English teachers, librarians, writers, and readers ...

SAN DIEGO, August 26, 2024--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...